These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37430160)

  • 21. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
    Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
    BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Clinical Diagnostic and Prognostic Value of Preoperative Serum Carcinoembryonic Antigen, CA19-9, and CA24-2 for Colorectal Cancer.
    Hou S; Jing J; Wang Y; Du L; Tian B; Xu X; Sun T; Shi Y
    Altern Ther Health Med; 2023 Sep; 29(6):192-197. PubMed ID: 37295009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of preoperative CA19-9 levels, cell differentiation, and age predicts survival for patients with gastric cancer before surgery.
    Yin HH; Xu MQ; Liu BZ; Tao L; Ma YJ; Li F; Zhang WJ
    Medicine (Baltimore); 2021 Dec; 100(49):e28017. PubMed ID: 34889247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
    Sun Z; Zhang N
    World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using Normalized Carcinoembryonic Antigen and Carbohydrate Antigen 19 to Predict and Monitor the Efficacy of Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer.
    Tang XH; Wu XL; Gan XJ; Wang YD; Jia FZ; Wang YX; Zhang Y; Gao XY; Li ZY
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer.
    Liang Y; Wang W; Fang C; Raj SS; Hu WM; Li QW; Zhou ZW
    Oncotarget; 2016 Aug; 7(31):49565-49573. PubMed ID: 27385101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
    He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
    Front Oncol; 2022; 12():829689. PubMed ID: 35296020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical value of serum CEA, CA19-9, CA72-4 and CA242 in the diagnosis and prognosis of gastric cancer].
    Zhu YB; Ge SH; Zhang LH; Wang XH; Xing XF; DU H; Hu Y; Li YA; Jia YN; Lin Y; Fan B; Ji JF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):161-4. PubMed ID: 22368025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel prognostic indicator combining inflammatory indicators and tumor markers for gastric cancer.
    Yu L; Jiang R; Chen W; Liu Y; Wang G; Gong X; Wang Y
    World J Surg Oncol; 2023 Feb; 21(1):50. PubMed ID: 36803398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence.
    Yamamoto M; Kurokawa Y; Miyazaki Y; Makino T; Takahashi T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    World J Surg; 2016 Aug; 40(8):1904-9. PubMed ID: 26969673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perioperative Serum Carcinoembryonic Antigen Levels Predict Recurrence and Survival of Patients with Pathological T2-4 Gastric Cancer Treated with Curative Gastrectomy.
    Uda H; Kanda M; Tanaka C; Kobayashi D; Inaoka K; Tanaka Y; Hayashi M; Iwata N; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
    Dig Surg; 2018; 35(1):55-63. PubMed ID: 28441659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of the serum carbohydrate antigen 19-9 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients.
    Kanda M; Fujii T; Takami H; Suenaga M; Inokawa Y; Yamada S; Nakayama G; Sugimoto H; Koike M; Nomoto S; Kodera Y
    Surg Today; 2014 Sep; 44(9):1692-701. PubMed ID: 24114022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early postoperative tumor marker responses provide a robust prognostic indicator for N3 stage gastric cancer.
    Zhang Q; Qu H; Sun G; Li Z; Ma S; Shi Z; Zhao E; Zhang H; He Q
    Medicine (Baltimore); 2017 Aug; 96(32):e7560. PubMed ID: 28796039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction models of colorectal cancer prognosis incorporating perioperative longitudinal serum tumor markers: a retrospective longitudinal cohort study.
    Li C; Zhao K; Zhang D; Pang X; Pu H; Lei M; Fan B; Lv J; You D; Li Z; Zhang T
    BMC Med; 2023 Feb; 21(1):63. PubMed ID: 36803500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis.
    Lin PC; Lin JK; Lin CC; Wang HS; Yang SH; Jiang JK; Lan YT; Lin TC; Li AF; Chen WS; Chang SC
    Int J Colorectal Dis; 2012 Oct; 27(10):1333-8. PubMed ID: 22426691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of normal levels of preoperative tumor markers in colorectal cancer.
    Ren G; Li R; Zheng G; Du K; Dan H; Wu H; Dou X; Duan L; Xie Z; Niu L; Tian Y; Zheng J; Feng F
    Sci Rep; 2023 Dec; 13(1):22830. PubMed ID: 38129505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma.
    Tokunaga R; Imamura Y; Nakamura K; Uchihara T; Ishimoto T; Nakagawa S; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Oyama S; Shono T; Naoe H; Saeki H; Oki E; Watanabe M; Sasaki Y; Maehara Y; Baba H
    Cancer Med; 2015 Nov; 4(11):1659-66. PubMed ID: 26310928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Grützmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
    Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
    Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined Use of Tumor Markers in Gastric Cancer: A Novel Method with Promising Prognostic Accuracy and Practicality.
    Zhang R; Chen X; Chen G; Zhao Z; Wei Y; Zhang F; Lin J; Nie R; Chen Y
    Ann Surg Oncol; 2023 Dec; 30(13):8561-8571. PubMed ID: 37718336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.